Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Pulmonology Reports
Erschienen in: Current Pulmonology Reports 4/2015

01.12.2015 | Smoking Cessation (S. Veeraraghavan, Section Editor)

Pharmacological therapies in smoking cessation: an evidence-based update

verfasst von: Joanne Shirine Allam, Christopher D. Ochoa

Erschienen in: Current Pulmonology Reports | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Smoking cessation presents a daunting challenge for clinicians; tobacco use impacts every major organ system and is responsible for considerable morbidity and mortality. Despite significant reductions in the rate of smoking over the past 50 years, tobacco use continues to burden the healthcare system. First-line therapies for smoking cessation include nicotine replacement, novel partial nicotinic agonists as well as antidepressant therapy. Herein, we review recent updates to the literature regarding nicotine replacement, bupropion, and varenicline. Re-emerging therapies such as cytisine are reviewed, as well as the novel concept of vaccination. Finally, the controversy surrounding electronic cigarettes and their debatable role in cessation therapy will be addressed as their popularity continues to grow.
Literatur
1.
The health consequences of smoking—50 years of progress: a report of the Surgeon General. 2014: U.S. Department of Health and Human Services.
2.
3.
Aubin HJ, Luquiens A, Berlin I. Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice. Br J Clin Pharmacol. 2014;77(2):324–36.PubMedCentralCrossRefPubMed
4.
5.
Stead LF et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012;11:CD000146.PubMed
6.
Brokowski L, Chen J, Tanner S. High-dose transdermal nicotine replacement for tobacco cessation. Am J Health Syst Pharm. 2014;71(8):634–8.CrossRefPubMed
7.
8.
Shahab L, Brose LS, West R. Novel delivery systems for nicotine replacement therapy as an aid to smoking cessation and for harm reduction: rationale, and evidence for advantages over existing systems. CNS Drugs. 2013;27(12):1007–19.CrossRefPubMed
9.
10.
Hughes JR et al. Are higher doses of nicotine replacement more effective for smoking cessation? Nicotine Tob Res. 1999;1(2):169–74.CrossRefPubMed
11.
12.
13.
Caldwell BO, Adamson SJ, Crane J. Combination rapid-acting nicotine mouth spray and nicotine patch therapy in smoking cessation. Nicotine Tob Res. 2014;16(10):1356–64.CrossRefPubMed
14.
Gonzales D et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):47–55.CrossRefPubMed
15.
Jorenby DE et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006;296(1):56–63.CrossRefPubMed
16.
Hurt RD et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med. 1997;337(17):1195–202.CrossRefPubMed
17.
Durcan MJ et al. The effect of bupropion sustained-release on cigarette craving after smoking cessation. Clin Ther. 2002;24(4):540–51.CrossRefPubMed
18.
Hughes JR et al. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2014;1:CD000031.PubMed
19.
Ebbert JO et al. Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial. JAMA. 2014;311(2):155–63.PubMedCentralCrossRefPubMed
20.
Rose JE, Behm FM. Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm. Am J Psychiatry. 2014;171(11):1199–205.PubMedCentralCrossRefPubMed
21.
Coe JW et al. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem. 2005;48(10):3474–7.CrossRefPubMed
22.
23.
Ebbert JO et al. Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial. JAMA. 2015;313(7):687–94.CrossRefPubMed
24.
Rigotti NA et al. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation. 2010;121(2):221–9.PubMedCentralCrossRefPubMed
25.
Singh S et al. Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis. CMAJ. 2011;183(12):1359–66.PubMedCentralCrossRefPubMed
26.
Prochaska JJ, Hilton JF. Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis. BMJ. 2012;344:e2856.PubMedCentralCrossRefPubMed
27.
Ware JH et al. Cardiovascular safety of varenicline: patient-level meta-analysis of randomized, blinded, placebo-controlled trials. Am J Ther. 2013;20(3):235–46.PubMed
28.•
Mills EJ et al. Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis. Circulation. 2014;129(1):28–41. Large meta-analysis examining the existing evidence regarding potential cardiovascular adverse effects of varenicline use for smoking cessation following FDA post-marketing reports of increased events.PubMedCentralCrossRefPubMed
29.
30.
31.
FDA Drug Safety Communication: FDA updates label for stop smoking drug Chantix (varenicline) to include potential alcohol interaction, rare risk of seizures, and studies of side effects on mood, behavior, or thinking. 2015 March 9, 2015 [cited 2015 June 1]; Available from: http://​www.​fda.​gov/​Drugs/​DrugSafety/​ucm436494.​htm.
32.
33.
Ahmed AI et al. Neuropsychiatric adverse events of varenicline: a systematic review of published reports. J Clin Psychopharmacol. 2013;33(1):55–62.CrossRefPubMed
34.
Meyer TE et al. Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System. Addiction. 2013;108(1):203–10.CrossRefPubMed
35.
West R et al. Placebo-controlled trial of cytisine for smoking cessation. N Engl J Med. 2011;365(13):1193–200.CrossRefPubMed
36.•
Walker N et al. Cytisine versus nicotine for smoking cessation. N Engl J Med. 2014;371(25):2353–62. An open label trial of 1310 patients to try to establish non-inferiority of cytisine to traditional NRT. It examined self-reported quit rates at 1 month.CrossRefPubMed
37.
Prochaska JJ, Das S, Benowitz NL. Cytisine, the world’s oldest smoking cessation aid. BMJ. 2013;347:f5198.CrossRefPubMed
38.
Yamin CK, Bitton A, Bates DW. E-cigarettes: a rapidly growing Internet phenomenon. Ann Intern Med. 2010;153(9):607–9.CrossRefPubMed
39.
Bhatnagar A et al. Electronic cigarettes: a policy statement from the American Heart Association. Circulation. 2014;130(16):1418–36.CrossRefPubMed
40.
McCarthy M. “Alarming” rise in popularity of e-cigarettes is seen among US teenagers as use triples in a year. BMJ. 2015;350:h2083.CrossRefPubMed
41.
Ebbert JO, Agunwamba AA, Rutten LJ. Counseling patients on the use of electronic cigarettes. Mayo Clin Proc. 2015;90(1):128–34.CrossRefPubMed
42.
43.
44.
Jensen RP et al. Hidden formaldehyde in e-cigarette aerosols. N Engl J Med. 2015;372(4):392–4.CrossRefPubMed
45.
Barrington-Trimis JL, Samet JM, McConnell R. Flavorings in electronic cigarettes: an unrecognized respiratory health hazard? JAMA. 2014;312(23):2493–4.PubMedCentralCrossRefPubMed
46.
Orr MS. Electronic cigarettes in the USA: a summary of available toxicology data and suggestions for the future. Tob Control. 2014;23 Suppl 2:ii18–22.PubMedCentralCrossRefPubMed
47.•
Bullen C et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013;382(9905):1629–37. Randomized controlled superiority trial comparing electronic cigarettes to placebo electronic cigarettes versus nicotine patches. Abstinence rates were examined 6 months following intervention.CrossRefPubMed
48.
Caponnetto P et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013;8(6):e66317.PubMedCentralCrossRefPubMed
49.•
McRobbie H et al. Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst Rev. 2014;12:CD010216. An important examination of the two RCTs and cohort studies currently available reporting on the possible efficacy of electronic cigarettes as a smoking cessation tool.PubMed
50.
51.
Raupach T, Hoogsteder PH, Onno van Schayck CP. Nicotine vaccines to assist with smoking cessation: current status of research. Drugs. 2012;72(4):e1–e16.PubMedCentralCrossRefPubMed
52.
Hoogsteder PH et al. Efficacy of the nicotine vaccine 3′-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial. Addiction. 2014;109(8):1252–9.CrossRefPubMed
53.
Koegelenberg CF et al. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial. JAMA. 2014;312(2):155–61.CrossRefPubMed
Metadaten
Titel
Pharmacological therapies in smoking cessation: an evidence-based update
verfasst von
Joanne Shirine Allam
Christopher D. Ochoa
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
Current Pulmonology Reports / Ausgabe 4/2015
Elektronische ISSN: 2199-2428
DOI
https://doi.org/10.1007/s13665-015-0125-5

Weitere Artikel der Ausgabe 4/2015

Current Pulmonology Reports 4/2015 Zur Ausgabe

Bronchiectasis (G Tino, Section Editor)

Diagnostic approach to bronchiectasis

Smoking Cessation (S. Veeraraghavan, Section Editor)

Waterpipe tobacco-smoking: a new smoking epidemic among the young?

Bronchiectasis (G Tino, Section Editor)

Inhaled antibiotics for bronchiectasis: are we there yet?

Smoking Cessation (S Veeraraghavan, Section Editor)

Computed tomography of smoking-related lung disease: review and update

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise